Jefferies Financial Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Buy
+5,503
New +$895K 0.01% 757
2026
Q1
– Sell
-6,156
Closed -$1.01M – 2129
2025
Q4
$1.01M Buy
+6,156
New +$964K 0.01% 1078
2025
Q3
– Sell
-14,280
Closed -$1.78M – 1640
2025
Q2
$1.78M Buy
14,280
+8,247
+137% +$1.05M 0.01% 561
2025
Q1
$768K Buy
+6,033
New +$929K 0.01% 906
2024
Q4
– Sell
-6,888
Closed -$1.03M – 1804
2024
Q3
$1.03M Buy
6,888
+1,600
+30% +$229K 0.01% 776
2024
Q2
$667K Buy
5,288
+3,205
+154% +$502K 0.01% 874
2024
Q1
$383K Buy
+2,083
New +$397K ﹤0.01% 1133
2023
Q4
– Sell
-5,773
Closed -$899K – 1941
2023
Q3
$918K Sell
5,773
-3,305
-36% -$540K 0.01% 858
2023
Q2
$1.28M Buy
+9,078
New +$1.46M 0.01% 824

Other funds holding RGEN

Jefferies Financial Group's RGEN Position: Q3 2026 in Review

Jefferies Financial Group opened a new position in Repligen (RGEN) in Q3 2026: 5,503 shares worth $1.06M. The stake represents 0.01% of the portfolio and ranks #757 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in RGEN as recently as Q4 2025.

Jefferies Financial Group first reported a position in RGEN in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.78M in Q2 2025. 523 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Jefferies Financial Group held 5,503 shares of Repligen worth $1.06M as of Q3 2026.
  • Repligen was a new Jefferies Financial Group position in Q3 2026.
  • Repligen made up 0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #757 holding.
  • Jefferies Financial Group first reported a position in Repligen in Q2 2023 and has held it in 9 quarters since.
  • Jefferies Financial Group's Repligen position peaked at $1.78M in Q2 2025.
  • 523 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.